| IMDX Shares Outstanding History Table | ||||||||||
Below is a table of the IMDX shares outstanding history going back to 5/5/2025:
Also see: IMDX Market Cap History IMDX YTD Return |
IMDX Shares Outstanding History — Insight Molecular Diagnostics Share Count Over Time
As of 3/19/2026 Insight Molecular Diagnostics has 32.17 million IMDX shares outstanding. Investors often track the IMDX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IMDX share count trends over time, with 4 historical shares outstanding datapoints presented, dating back to 5/5/2025.
| IMDX Shares Outstanding History Chart | |||||||||||
IMDX Historical Shares Outstanding: +14.32% CAGR 
Mouse over chart for data details
| |||||||||||
| IMDX Stock Price Chart |
| About Insight Molecular Diagnostics Inc |
| Oncocyte Corporation is a precision diagnostics company. Co. is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. Co.'s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. We show 4 historical shares outstanding datapoints in our coverage of IMDX's shares outstanding history. Understanding the changing numbers of IMDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMDX by allowing them to research IMDX shares outstanding history as well as any other stock in our coverage universe. |
| IMDX Current Stock Quote |
Quotes delayed 20 minutes  Free IMDX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| IMDX Share Performance |
| Shares Outstanding Peers |
| Insight Molecular Diagnostics (IMDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMDZ Shares Outstanding History IMGN Shares Outstanding History IMGO Shares Outstanding History IMMU Shares Outstanding History IMMX Shares Outstanding History IMMY Shares Outstanding History IMNM Shares Outstanding History IMNN Shares Outstanding History IMNP Shares Outstanding History IMPL Shares Outstanding History More Healthcare companies » |
IMDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
